Study details
Enrolling now
RISE Trial
Dartmouth-Hitchcock Medical Center
NCT IDNCT05956158ClinicalTrials.gov data as of Apr 2026
Target enrollment
83
Study length
about 3 years
Ages
18+
Locations
1 site in NH
What this study is about
Researchers are testing whether a behavioral treatment and sleep education treatment can help people with Crohn's disease who have insomnia. The trial will last for 1098 days and involve approximately 83 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Behavioral Treatment
- 2.Participate in Sleep Education Treatment
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in Crohn's disease symptoms as measured by the Patient Reported Outcomes 3, Change in insomnia symptoms as measured by the Insomnia Severity Index
Body systems
Gastroenterology